These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 19797206)
1. Susceptibility genes and progression in age-related maculopathy: a study of single eyes. Farwick A; Wellmann J; Stoll M; Pauleikhoff D; Hense HW Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):731-6. PubMed ID: 19797206 [TBL] [Abstract][Full Text] [Related]
2. An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population. Matušková V; Zeman T; Ewerlingová L; Hlinomazová Z; Souček J; Vlková E; Goswami N; Balcar VJ; Šerý O Acta Ophthalmol; 2020 Sep; 98(6):e691-e699. PubMed ID: 31970928 [TBL] [Abstract][Full Text] [Related]
3. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans. Contreras AV; Zenteno JC; Fernández-López JC; Rodríguez-Corona U; Falfán-Valencia R; Sebastian L; Morales F; Ochoa-Contreras D; Carnevale A; Silva-Zolezzi I Mol Vis; 2014; 20():105-16. PubMed ID: 24453474 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population. Connolly E; Rhatigan M; O'Halloran AM; Muldrew KA; Chakravarthy U; Cahill M; Kenny RA; Doyle SL Br J Ophthalmol; 2018 Dec; 102(12):1691-1695. PubMed ID: 29453225 [TBL] [Abstract][Full Text] [Related]
5. Association of genetic variants rs641153 ( Neto JM; Viturino MG; Ananina G; Bajano FF; Costa SMDS; Roque AB; Borges GF; Franchi R; Rim PH; Medina FM; Costa FF; Melo MB; de Vasconcellos JP Exp Biol Med (Maywood); 2021 Nov; 246(21):2290-2296. PubMed ID: 34233521 [TBL] [Abstract][Full Text] [Related]
6. No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18. van Asten F; Chiu CY; Agrón E; Clemons TE; Ratnapriya R; Swaroop A; Klein ML; Fan R; Chew EY; Ophthalmology; 2019 Nov; 126(11):1541-1548. PubMed ID: 31358387 [TBL] [Abstract][Full Text] [Related]
7. Variations in five genes and the severity of age-related macular degeneration: results from the Muenster aging and retina study. Farwick A; Dasch B; Weber BH; Pauleikhoff D; Stoll M; Hense HW Eye (Lond); 2009 Dec; 23(12):2238-44. PubMed ID: 19169232 [TBL] [Abstract][Full Text] [Related]
8. Association of Single-Nucleotide Polymorphisms in Age-Related Macular Degeneration With Pseudodrusen: Secondary Analysis of Data From the Comparison of AMD Treatments Trials. Lin LY; Zhou Q; Hagstrom S; Maguire MG; Daniel E; Grunwald JE; Martin DF; Ying GS; JAMA Ophthalmol; 2018 Jun; 136(6):682-688. PubMed ID: 29801032 [TBL] [Abstract][Full Text] [Related]
9. ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study. Chakravarthy U; McKay GJ; de Jong PT; Rahu M; Seland J; Soubrane G; Tomazzoli L; Topouzis F; Vingerling JR; Vioque J; Young IS; Sofat R; Hingorani AD; Fletcher AE Ophthalmology; 2013 Feb; 120(2):342-8. PubMed ID: 23098369 [TBL] [Abstract][Full Text] [Related]
10. Risk alleles in CFH and ARMS2 are independently associated with systemic complement activation in age-related macular degeneration. Smailhodzic D; Klaver CC; Klevering BJ; Boon CJ; Groenewoud JM; Kirchhof B; Daha MR; den Hollander AI; Hoyng CB Ophthalmology; 2012 Feb; 119(2):339-46. PubMed ID: 22133792 [TBL] [Abstract][Full Text] [Related]
11. The Incidence and Progression of Age-Related Macular Degeneration over 15 Years: The Blue Mountains Eye Study. Joachim N; Mitchell P; Burlutsky G; Kifley A; Wang JJ Ophthalmology; 2015 Dec; 122(12):2482-9. PubMed ID: 26383995 [TBL] [Abstract][Full Text] [Related]
12. The contribution of genetic factors to phenotype and progression of drusen in early age-related macular degeneration. Dietzel M; Pauleikhoff D; Arning A; Heimes B; Lommatzsch A; Stoll M; Hense HW Graefes Arch Clin Exp Ophthalmol; 2014 Aug; 252(8):1273-81. PubMed ID: 24970616 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss. Francis PJ; Hamon SC; Ott J; Weleber RG; Klein ML J Med Genet; 2009 May; 46(5):300-7. PubMed ID: 19015224 [TBL] [Abstract][Full Text] [Related]
14. Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration. Caire J; Recalde S; Velazquez-Villoria A; Garcia-Garcia L; Reiter N; Anter J; Fernandez-Robredo P; Alfredo García-Layana ; JAMA Ophthalmol; 2014 May; 132(5):528-34. PubMed ID: 24557084 [TBL] [Abstract][Full Text] [Related]
15. Prevalence, Risk, and Genetic Association of Reticular Pseudodrusen in Age-related Macular Degeneration: Age-Related Eye Disease Study 2 Report 21. Domalpally A; Agrón E; Pak JW; Keenan TD; Ferris FL; Clemons TE; Chew EY Ophthalmology; 2019 Dec; 126(12):1659-1666. PubMed ID: 31558345 [TBL] [Abstract][Full Text] [Related]
16. Incidence and progression of reticular drusen in age-related macular degeneration: findings from an older Australian cohort. Joachim N; Mitchell P; Rochtchina E; Tan AG; Wang JJ Ophthalmology; 2014 Apr; 121(4):917-25. PubMed ID: 24332537 [TBL] [Abstract][Full Text] [Related]
17. Joint association of complement component 3 and CC-cytokine ligand2 (CCL2) or complement component 3 and CFH polymorphisms in age-related macular degeneration. Bonyadi M; Jabbarpoor Bonyadi MH; Yaseri M; Mohammadian T; Fotouhi N; Javadzadeh A; Soheilian M Ophthalmic Genet; 2017; 38(4):365-370. PubMed ID: 28095095 [TBL] [Abstract][Full Text] [Related]
18. Progression of geographic atrophy and genotype in age-related macular degeneration. Klein ML; Ferris FL; Francis PJ; Lindblad AS; Chew EY; Hamon SC; Ott J Ophthalmology; 2010 Aug; 117(8):1554-9, 1559.e1. PubMed ID: 20381870 [TBL] [Abstract][Full Text] [Related]
19. No clinically significant association between CFH and ARMS2 genotypes and response to nutritional supplements: AREDS report number 38. Chew EY; Klein ML; Clemons TE; Agrón E; Ratnapriya R; Edwards AO; Fritsche LG; Swaroop A; Abecasis GR; Ophthalmology; 2014 Nov; 121(11):2173-80. PubMed ID: 24974817 [TBL] [Abstract][Full Text] [Related]
20. CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration. Awh CC; Lane AM; Hawken S; Zanke B; Kim IK Ophthalmology; 2013 Nov; 120(11):2317-23. PubMed ID: 23972322 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]